BioTuesdays

Category - Markets

atyr logo
Markets

HCW ups aTyr Pharma to buy; PT $13

H.C. Wainwright upgraded aTyr Pharma (NASDAQ:LIFE) to “buy” from “neutral” with a $13 price target, citing a “positive shift” at the company ahead of anticipated news flow. The stock closed at $3.81 on Aug. 14. Analyst...

August 17, 2020
Itamar Medical
Markets

AGP ups Itamar Medical PT to $28 from $22.75

Alliance Global Partners raised its price target for Itamar Medical (NASDAQ:ITMR) to $28 from $22.75 after the company’s second quarter results beat expectations. However, the stock closed at $22.02, down $3.84, on Aug...

August 12, 2020
Senseonics
Markets

BTIG ups Sensenonics to buy; PT to $1

BTIG upgraded Sensenonics Holdings (NYSE American:SENS) to “buy” from “neutral” with a price target of $1, citing a commercial collaboration with Ascensia Diabetes Care, a financing agreement with Ascensia’s parent, PHC...

August 11, 2020
Markets

HCW starts Lumos Pharma at buy; PT $33

H.C. Wainwright initiated coverage of Lumos Pharma (NASDAQ:LUMO) with a “buy” rating and $33 price target. The stock closed at $13.80 on Aug. 3. Analyst Edward White writes that the company’s LUM-201 drug candidate is...

August 4, 2020
Nkarta Therapeutics
Markets

Stifel starts Nkarta at buy; PT $41

Stifel launched coverage of Nkarta (NASDAQ:NKTX) with a “buy” rating and 12-month target price of $41. The stock closed at $26.58 on Aug. 3. Nkarta is focused on the discovery, development, and potential...

August 4, 2020
Geron
Markets

Stifel starts Geron at buy; PT $3

Stifel initiated coverage of Geron (NASDAQ:GERN) with a “buy” rating and $3 price target. The stock closed at $1.59 on July 31. Geron is focused on the development and potential commercialization of a single product...

August 3, 2020
Onconova Logo
Markets

Maxim ups Onconova Therapeutics PT to $3 from $1.25

Maxim Group raised its price target for Onconova Therapeutics (NASDAQ:ONTX) to $3 from $1.25 after the company announced that the required number of survival events for the pivotal Phase 3 INSPIRE study of IV rigosertib...

July 30, 2020